Status:
COMPLETED
Dexmedetomidine on Intraoperative Somatosensory and Motor Evoked Potential Monitoring During Neurosurgery in Pediatric Patients
Lead Sponsor:
Oregon Health and Science University
Conditions:
Tethered Spinal Cord
Brain Tumor
Eligibility:
All Genders
2-12 years
Phase:
NA
Brief Summary
The investigators want to know if using the study drug dexmedetomidine will improve nerve wave readings during neurosurgery. These readings are done many times during surgery while the patient is asle...
Detailed Description
Somatosensory evoked potential (SSEP) and motor evoked potential (MEP) have become an integral component in intraoperative care of patients and have resulted in a high degree of sensitivity in predict...
Eligibility Criteria
Inclusion
- Pediatric patients between 2 and 12 years old
- Undergoing neurosurgery and
- Requiring SSEP/ MEP measurements
Exclusion
- Patients younger than 2 and older than 12 years
- Patients with known bradyarrhythmias
- Patients with severe liver disease
- Conditions that may alter reading, e.g. neuromuscular diseases
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01512147
Start Date
December 1 2011
End Date
April 1 2018
Last Update
April 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohsu - Oregon Health and Science University
Portland, Oregon, United States, 97239